The results come from a study conducted at Rambam Healthcare Campus in Haifa, Israel. A team led by principal investigator Dr. Ory Keynan compared the views of pedicle screws displayed by Vuze in 20 patients with postinsertion 3D verification scans; all of these comparisons demonstrated high accuracy, the company noted.

Vuze System uses image processing to overlay graphical representations of surgical tools on intraoperative 2D x-ray images onto a patient's preoperative CT scan. It was cleared by the U.S. Food and Drug Administration in early 2022, and the company holds seven patents for it in the U.S., Europe, and Asia.